Company Profile

THYROCARE TECHNOLOGIES LTD.

NSE : THYROCAREBSE : 539871ISIN CODE : INE594H01019Industry : Hospital & Healthcare ServicesHouse : MNC
BSE463.15-0.45 (-0.1 % )
PREV CLOSE (Rs.) 463.60
OPEN PRICE (Rs.) 465.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 690
TODAY'S LOW / HIGH (Rs.)458.00 465.00
52 WK LOW / HIGH (Rs.)425.25 697
NSE463.00 -0.85 (-0.18 % )
PREV CLOSE(Rs.) 463.85
OPEN PRICE (Rs.) 461.80
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 7656
TODAY'S LOW / HIGH(Rs.) 457.05 465.00
52 WK LOW / HIGH (Rs.)425.05 694.8

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 3.17976
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 29.00
ROCE (%) 33.55
Incorporation Year : 2000

Management Info :

A Velumani - Chairman A Velumani - Managing Director

Registered Office :

Address : D - 37/1, Ttc Industrial Area,M I D C,Turbhe,
Navi Mumbai,
Maharashtra-400703

Phone : 91-022-27622762

Website : www.thyrocare.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
24Jun06-24-2019$Thyrocare Technologies informs about analyst meetings Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed about forthcoming Analyst Meetings to be held at the Corporate Office of the Company. Meeting with the representative(s) of Securities Investment Management Pvt. Ltd., will be held at 3.30 PM on Wednesday, June 26, 2019; and meeting with the representative(s) of HDFC Securities Limited, will be held at 4.30 PM on Wednesday, June 26, 2019. These meetings are subject to any last minute changes.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
23May05-23-2019$Thyrocare Technologies informs about conference call Thyrocare Technologies infor

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that the representative(s) of SAIF Partners would be having a Con-call with the company by 3.00 P.M. today (Thursday, May 23, 2019).

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disc..
22May05-22-2019$Cyient, Indiabulls Housing Finance and Infosys to see some action today Cyient, Indiabulls Housing F

Cyient has signed a partnership agreement with OneStrand Inc. to offer interactive technical publication solutions. This agreement combines Cyient’s global reach and long history in authoring, illustrating, designing, and converting technical publications with OneStrand’s world leading S1000D software and technical services.

Indiabulls Housing Finance has received approval for issuance of $350 million 6.375% payable semi-annually (6.29% nominal monthly) Senior Secured Notes due May 2022 under the updated $1,500 million Secured Euro Medium Term Note Programme of the Company.

Infosys Finacle, part of EdgeVerve Systems, a wholly owned subsidiary of Infosys, and Global Treasure Bank (GTB), successfully implemented the Finacle Core Banking solution at the Bank. GTB now leverages Finacle’s proven platform to power its retail and corporate operations across 163 branches across the country, engaging its customers with a truly digital banking experience and an enriched product and services portfolio.

UFO Moviez India has received approval for dissolution of UFO Lanka, a wholly owned subsidiary of the Company. As there are no operations in UFO Lanka, the Board of Directors of the Company have approved dissolution of UFO Lanka at its meeting held on May 21, 2019.

Alkali Metals has received an Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Visakhapatnam Unit in Andhra Pradesh. The Visakhapatnam unit manufactures Active Pharmaceutical Ingredients (APIs) and other Chemical intermediates. The EIR from USFDA indicates closure of the inspection and that the Unit is in acceptable state of Compliance of Current Good Manufacturing Practice (CGMP).

Vodafone Idea has entered into partnership with Hyundai AutoEver India, a subsidiary of Hyundai Motor Group, for roll-out of connected car services. The tie-up will enable Hyundai cars, starting with its recently launched SUV Hyundai VENUE, to offer what it terms ‘advanced connected car functionality’. The partnership will see Hyundai deploy a connected solution in Indian market with integration of eSIMS with Voice, 3G/4G data, SMS, etc.

Thyrocare Technologies has received Letter of Acceptance (LoA) for the tender floated by Municipal Corporation of Greater Mumbai (MCGM) for outsourcing of laboratory investigative services ‘Aapli Chikitsa’. The acceptance letter, authorized to provide laboratory investigative services ‘Aapli Chikitsa’ over a period of 4 years from the commencement of operations, to the MCGM affiliated hospitals and clinics in western suburban zone and city zone of Mumbai.

Cyient has signed a partnership agreement with OneStrand Inc. t..
21May05-21-2019$Thyrocare Technologies receives LoA from MCGM for outsourcing laboratory services Thyrocare Technologies recei

Thyrocare Technologies has received Letter of Acceptance (LoA) for the tender floated by Municipal Corporation of Greater Mumbai (MCGM) for outsourcing of laboratory investigative services ‘Aapli Chikitsa’.

The acceptance letter, authorized to provide laboratory investigative services ‘Aapli Chikitsa’ over a period of 4 years from the commencement of operations, to the MCGM affiliated hospitals and clinics in western suburban zone and city zone of Mumbai. The total contract cost of the tender to be executed over the period of 4 years is for Rs 53.23 crore, with an assurance of about 60% of total samples test per year. The operation to be commences within next 30 days.

Thyrocare Technologies provides hospital services and are the industry leader, trend setter and innovators in Indian Diagnostic industry.

Thyrocare Technologies has received Letter of Acceptance (LoA)..
21May05-21-2019$ Announcement under Regulation 30 (LODR)-Meeting Updates Announcement under Regulati
Sub: Update on Outcome of Board Meeting held on 18-05-2019 Please refer to our letter dated 18th May 2019, intimating about the decisions taken at the Board Meeting held on 18-05-2019. We wish to add that at the above Board Meeting, when the Auditors pointed out the impairment of investment in Nueclear Healthcare Limited (NHL), the wholly owned subsidiary, Dr. A. Velumani, Chairman, Managing Director & CEO has offered to buy the entire shareholding of the Company in NHL at the current investment value of Rs. 194.67 crores to ensure that there is no loss to the public shareholders. However, all required formalities will be complied with by the Company for such a transaction. We were waiting for the concurrence from the Auditors to intimate this and hence the delay.
Sub: Update on Outcome of Board Meeting held on 18-05-2019 Ple..
Financials More
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit208.9952.3
Gross Profit 330.8 1468.6
Operating Profit 371.51618
Net Sales 972.93702.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Dr Lal Pathlabs (BSE)
 1089.50 (1.69%)
M.Cap ( in Cr)
9080.07
Dr Agarwals Eye Hsp (BSE)
 266.95 (3.47%)
M.Cap ( in Cr)
125.47
Metropolis Health. (BSE)
 1038.00 (0.51%)
M.Cap ( in Cr)
5208.55
Shalby Ltd. (BSE)
 96.45 (3.60%)
M.Cap ( in Cr)
1041.75
Narayana Hrudayalay (BSE)
 224.90 (1.26%)
M.Cap ( in Cr)
4596.07
Shareholding Pattern More
NON-INSTITUTION 8.88 %
PROMOTERS 65.71 %
MUTUAL FUNDS/UTI 13.41 %
FI/BANKS/INSURANCE 0.34 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes